| XLS |
|
|
|
€ million |
2011 |
2010 |
Book value January 1 |
5.0 |
1.6 |
Additions |
– |
– |
Share of profit |
0.7 |
0.9 |
Impairment losses |
–1.7 |
– |
Disposals |
–3.8 |
– |
Currency translation |
–0.2 |
0.3 |
Changes in scope of consolidation |
– |
2.2 |
Book value December 31 |
– |
5.0 |
Impairment losses include a decline in the value of an associated company within the Merck Millipore division that is disclosed in the income statement under “Investment result.” Investments at equity were divested during fiscal 2011.